ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Wei Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0056-2532; OpenAlex author ID A5101475507. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Last author DOI 10.1038/s41419-019-1896-3 ↗
Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer. Last author DOI 10.3892/or.2018.6216 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qian Li · 1 shared paper, 2019 · strength 0.11
- Paper LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. DOI 10.1038/s41419-019-1896-3 ↗
Song He · 1 shared paper, 2018 · strength 0.10
- Paper Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer. DOI 10.3892/or.2018.6216 ↗
Weiwei Sheng · 1 shared paper, 2018 · strength 0.10
- Paper Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer. DOI 10.3892/or.2018.6216 ↗
Ming Dong · 1 shared paper, 2018 · strength 0.10
- Paper Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer. DOI 10.3892/or.2018.6216 ↗
Jianping Zhou · 1 shared paper, 2018 · strength 0.10
- Paper Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer. DOI 10.3892/or.2018.6216 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.